Health Secretary RFK Jr. Authorizes Use of Unapproved Peptides Despite FDA Opposition
U.S. Health Secretary Robert F. Kennedy Jr. has unilaterally authorized the use of several unapproved peptides, including BPC-157, TB-500, Mots-C, KPV, epitalon, and semax. This decision comes despite formal warnings from FDA scientists in July advising against such a move. The new directive broadens patient access to these substances but maintains regulatory guardrails by requiring patient-specific prescriptions and mandatory reporting of adverse effects. The decision marks a significant shift in the administration's approach to peptide regulation, bypassing previous scientific recommendations from the FDA.
Topics: FDA Regulation Health Policy Medical Approval Peptides RFK Jr.